SecBot SecBot

Pandemic and All-Hazards Preparedness and Response Act

S. 2333 Sen. Bob Casey (D-PA) In committee
Bill text PDF
  1. Introduced Jul 18
  2. Committee Jul 18
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jul 18, 2023Next: Senate vote
1148d ago Sep 6, 2023: Placed on Senate Legislative Calendar under General Orders. Calendar No. 202.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
9companies, 10 filings
Subscribe to see spend
Member trades
17trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

9 companies
Companies by sector
Biotech & Pharma 5Medical Devices & Healthcare 3Technology & Software 1
Search all 9 companies, their asks and price moves Subscribe

Summary

Pandemic and All-Hazards Preparedness and Response Act

Full summary7 paragraphs

This bill reauthorizes through FY2028 and modifies public health preparedness and response programs and activities. The bill also addresses potential shortages of drugs and medical devices.

Affected public health programs and activities include

- the Public Health Emergency Preparedness Program and other programs that support state, territorial, tribal, and local preparedness and response;

- activities that support the development of medical countermeasures, diagnostic testing capacity, and the administration of the Strategic National Stockpile;

- requirements concerning biosecurity, including with respect to biological agents and toxins that pose a threat to animal, plant, and human health; and

- the Volunteer Medical Reserve Corps and other programs to enable volunteer health providers and other health professionals to respond during disasters and emergencies.

The bill also (1) establishes specific procedures with respect to certain claims for compensation for deaths or injuries in association with COVID-19 vaccinations or medical countermeasures; (2) establishes programs to address the needs of individuals with disabilities and other at-risk individuals during public health emergencies; and (3) makes various changes to address and mitigate shortages of drugs and devices, including by expanding certain reporting and notification requirements.

Library of Congress summary, Jul 18, 2023

Summary versions
  • Introduced in SenateJul 18, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.